Fruit Fly Study Leads to New Understanding of How mRNA Regulates Gene Expression
|
By LabMedica International staff writers Posted on 02 Apr 2014 |
A study on heat sensitivity in fruit flies has led to a new understanding of how gene expression is regulated by mRNAs in a fashion that is independent of both DNA and protein.
Investigators at the Washington University School of Medicine (St. Louis, MO, USA) were studying the genetic mechanism that controls the behavior of a mutant variety of Drosophila that was unusually sensitive to high temperatures. These flies carried a mutated copy of a gene called seizure (sei) that rendered them so sensitive to heat that a rise in temperature of even 10 degrees was sufficient to send them into seizures.
"When we looked at the sei gene, we noticed that there is another gene on the opposite strand of the double-stranded DNA molecule called pickpocket 29 (ppk29)," said senior author Dr. Yehuda Ben-Shahar, assistant professor of biology at the Washington University School of Medicine. "This was interesting because sei codes for a protein ‘gate’ that lets potassium ions out of the neuron and pickpocket 29 codes for a gate that lets sodium ions into the neuron."
The investigators generated a series of transgenic lines of Drosophila with different ratios of sei and ppk29. They reported in the March 18, 2014, online edition of the journal eLife that mRNA originating from ppk29 was regulating the mRNA from the sei gene. The regulatory component of ppk29 was identified as the untranslated 3' UTR end of the mRNA strand. When this section of ppk29 mRNA formed a double stranded segment with complementary DNA from sei it resulted in the destruction of the sei strand through the combination of the Dicer enzyme and RISC (RNA-induced silencing complex) assembly. Thus, the gene coding a sodium channel was found to regulate the expression of the potassium channel gene.
“Our findings show that mRNAS, which are typically thought to act solely as the template for protein translation, can also serve as regulatory RNAs, independent of their protein-coding capacity,” said Dr. Ben-Shahar. “They are not just messengers but also actors in their own right.”
Related Links:
Washington University School of Medicine
Investigators at the Washington University School of Medicine (St. Louis, MO, USA) were studying the genetic mechanism that controls the behavior of a mutant variety of Drosophila that was unusually sensitive to high temperatures. These flies carried a mutated copy of a gene called seizure (sei) that rendered them so sensitive to heat that a rise in temperature of even 10 degrees was sufficient to send them into seizures.
"When we looked at the sei gene, we noticed that there is another gene on the opposite strand of the double-stranded DNA molecule called pickpocket 29 (ppk29)," said senior author Dr. Yehuda Ben-Shahar, assistant professor of biology at the Washington University School of Medicine. "This was interesting because sei codes for a protein ‘gate’ that lets potassium ions out of the neuron and pickpocket 29 codes for a gate that lets sodium ions into the neuron."
The investigators generated a series of transgenic lines of Drosophila with different ratios of sei and ppk29. They reported in the March 18, 2014, online edition of the journal eLife that mRNA originating from ppk29 was regulating the mRNA from the sei gene. The regulatory component of ppk29 was identified as the untranslated 3' UTR end of the mRNA strand. When this section of ppk29 mRNA formed a double stranded segment with complementary DNA from sei it resulted in the destruction of the sei strand through the combination of the Dicer enzyme and RISC (RNA-induced silencing complex) assembly. Thus, the gene coding a sodium channel was found to regulate the expression of the potassium channel gene.
“Our findings show that mRNAS, which are typically thought to act solely as the template for protein translation, can also serve as regulatory RNAs, independent of their protein-coding capacity,” said Dr. Ben-Shahar. “They are not just messengers but also actors in their own right.”
Related Links:
Washington University School of Medicine
Latest BioResearch News
- Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
- Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
- Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
- Single-Cell Method Measures RNA and Proteins to Reveal Immune Responses
- Study Links Midlife Vitamin D to Lower Tau in Alzheimer's
- International Consensus Standardizes Tumor Microbiota Detection and Reporting
- Common Metablolic Enzyme Could Predict Response to Cancer Immunotherapy
- Newly Identfied Genetic Variants in MND Support Prognosis and Family Testing
- Innate Immunity Variants Associated With Earlier Breast Cancer in BRCA1 Carriers
- Genetic Cause Identified for Severe Infant Epilepsy
- Study Reveals Diagnostic and Therapeutic Target in Rare Pancreatic Tumors
- Researchers Identify Survival Pathway Undermining Targeted Cancer Drugs
- Large-Scale Study Maps DNA Damage Signatures Across Multiple Cancers
- Study Identifies Distinct Immune Signatures to Early Depression and Psychosis
- Genetic Mutation Behind Aggressive Adult Leukemia Offers Treatment Clues
- Disease Gene Discovery Advances Diagnosis of Rare Movement Disorders
Channels
Clinical Chemistry
view channel
Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation
Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms
Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read moreMolecular Diagnostics
view channel
Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary
Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Blood Test Enables Early Detection and Classification of Glioma
High-grade gliomas, particularly glioblastoma, are fast-growing brain tumors that are often diagnosed late and typically require invasive procedures for confirmation. Current pathways rely on symptoms,... Read more
Multi-Biomarker Blood Test Detects Early-Stage Cancers Across Types
Abbott is showcasing its Cancerguard multi-cancer early detection (MCED) test at the American Association for Cancer Research (AACR) Annual Meeting 2026, where new data highlight continued progress in... Read more
New Sample-to-Answer PCR System Supports High-Throughput Infectious Disease Testing
Clinical laboratories face mounting demand for rapid, high‑volume molecular testing for infectious diseases, including routine monitoring in immunocompromised patients. Consolidated, sample‑to‑answer workflows... Read moreHematology
view channel
Routine Blood Test Parameters Link Anemia to Cancer Risk and Mortality
Anemia detected in routine care can signal underlying pathology and is frequently encountered in adults. Because it is defined by hemoglobin levels below the normal range, it is often evaluated with red... Read more
Prognostic Tool Guides Personalized Treatment in Rare Blood Cancer
Chronic myelomonocytic leukemia (CMML) is a rare blood cancer in which acquired genetic mutations in bone marrow stem cells drive disease. Stem cell transplantation is the only curative option but carries... Read moreImmunology
view channel
Immune Aging Clock Quantifies Immunosenescence and Identifies Therapeutic Target
Immune aging undermines host defense and contributes to multiple age-related diseases, yet its heterogeneity complicates measurement and intervention. Clinical laboratories increasingly seek objective... Read more
Study Finds Influenza Often Undiagnosed in Winter Deaths
Seasonal influenza drives substantial excess mortality, yet its contribution is often obscured when infections go undiagnosed near the time of death. Many deaths occur outside hospitals or in older adults... Read moreMicrobiology
view channel
Rapid Blood-Culture Susceptibility Panel Expands Coverage for Gram-Negative Infections
Gram-negative bloodstream infections and sepsis demand fast, precise antimicrobial therapy, yet conventional susceptibility workflows can delay targeted treatment. Clinical laboratories need platforms... Read more
Antibiotic Resistance Genes Found in Newborns Within Hours of Birth
Antibiotic resistance in early life is challenging to characterize, particularly around the timing and drivers of gene acquisition in newborns. Meconium, the first stool passed by infants, was long considered... Read morePathology
view channel
AI Precision Tests Deliver Cancer Risk Insights from Routine H&E Slides
Reliable prognostic profiling and biomarker screening are essential to guide oncology treatment decisions, while laboratories must balance speed and resource constraints. Earlier identification of high‑risk... Read more
Study Reveals Moleclar Mechanism Driving Aggressive Skin Cancer
Cutaneous squamous cell carcinoma (cSCC) is the world’s second most common skin cancer, and while many cases are treatable, a subset becomes highly aggressive and therapy‑resistant. Identifying molecular... Read moreTechnology
view channel
AI Tool Predicts Non-Response to Targeted Therapy in Colorectal Cancer
Advanced bowel cancer remains difficult to treat, and many patients receive targeted therapies that do not help them but still cause harm. Clinicians need reliable ways to identify likely responders before... Read more
Integrated System Streamlines Pre-Analytical Workflow for Molecular Testing
Pre-analytical variation remains a leading source of inconsistent molecular test results and added costs, particularly when laboratories rely on multiple instruments and protocols. Standardizing nucleic... Read moreIndustry
view channel
QuidelOrtho Adds Ultra-Fast PCR Platform with LEX Acquisition
QuidelOrtho Corporation has completed the acquisition of LEX Diagnostics for approximately USD 100 million in cash. The transaction adds the LEX VELO System to QuidelOrtho’s portfolio. The platform received U.... Read more
Seegene Showcases Real-Time PCR Data Analytics Platform at ESCMID
Seegene introduced STAgora, a real-time data analytics platform built on aggregated statistical testing data, at ESCMID Global 2026 in Munich, where it also presented an enhanced model of its automated... Read more
Roche Affiliate Expands MRD Portfolio with SAGA Acquisition
Foundation Medicine, Inc., an independent affiliate of Roche, announced plans to expand its monitoring portfolio with SAGA Diagnostics’ Pathlight, a personalized, tumor-informed molecular residual disease... Read more







